December 17, 2015: Draft EMA Pain Guideline Cites Multiple IMMPACT/ACTTION Articles
The European Medicines Agency (EMA) has released an updated draft "Guideline on the Clinical Development of Medicinal Products Intended for the Treatment of Pain." The draft guideline references multiple IMMPACT/ACTTION articles that have presented recommended considerations for the design, analysis, and interpretation of adult and pediatric clinical trials of pain treatments. This important attention to ACTTION's efforts provides independent recognition of its contributions to advancing the development of improved pain treatments. The draft guideline is available here.
News
ACTTION Guide to Clinical Trials of Pain Treatments
The ACTTION Guide to Clinical Trials of Pain Treatments consists of two supplements published in the journal Pain Reports that include a series of articles describing research designs and methods, study conduct, outcome measures, data analyses and interpretation, and reporting recommendations for clinical trials of acute and chronic pain treatments.
Part I includes 9 articles that can be found here, and Part II includes 6 articles that can be found here.